<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 60 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page59.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=60">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 60 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 60</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=60"><img src="../thumb/60.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Central Nervous System - 1.5.3                                                  2020-04 / 29
       RISPIDE, (Unicorn) Abex [P/S]  are promin., conduct & disrupt.behav.disords.in childr. 5-12 yrs.with   yngit., rhinit., GI disturbs., dry mouth, rais. liv.enzym., jaund., hepatit.,
       Risperidone                   subaveg.intellect.funct./ ment.retard. where destruct.behav.is promin.  skin reacts., hyperton., myalg., UTI, galactorrh., menstr.chang., pria-
       Indications: Ac.& chron.schizophren.psychos.& relat. psychos.  (S5) TABS, 41/2.6.5/0937, 0938, 0939, 0940  pism, incr.weight, asthen., periph.oed., dysarthr., flu-like sympt., incr.
       where posit.&/or negat.sympts.are promin., affect.sympts.assoc.  711537-001: 1 mg, 30, R216,95  sweat., headache, chest/ back pain, ser.transamin.lev., cholesterol &
       with schizophren., maint. clinic. improvem.where init.treatm.reponse   711534-001: 2 mg, 30, R433,92  triglyceride ser.elev., reduc.plasma thyroid.conc., gamma T-lev.elev.,
       shown, behav.disturbs.in pts.with dement.when aggressiven./activ.  711536-001: 3 mg, 30, R827,74  incr.aspirat.pneum./seiz.risk in Alzheimers pts., poss.ac.withdr.sympt.
       disturbs./psychot.sympts.are promin., conduct & disrupt.behav.dis-  711538-001: 4 mg, 30, R1 125,47  Special precautions: Monit.gluc.contr.of exist. diabet./hypergly-
       ords.in childr. 5-12 yrs.with sub-aveg.intellect.funct./ment. retard.   Dosage: Schizophren: When switch.from other antipsychot. & if   caem.sympt.in those at risk, pts. develop. hyperglycaem.sympt.dur.
       where destruct.behav.is promin.  medic.appropriate discont.prev. treatm.grad.& if switch.from depot   ther.to undergo fast.bld.gluc.test, cont anti-diab.meds.poss. necess.
       (S5) TABS, 44/2.6.5/0673, 0674, 0675  antipsychot. init. Risponz in place of next inj. Re-eval.need for cont.ex-  desp.ther.discont., caref.benef./risk assess. advis.in elderly & esp.dur.
       723314-001: 0,5 mg, 30, R119,81  ist.anti-Parkinson meds.period. Dos. above 10 mg/day have not been   init.dos.per., concom. antihypertens./meds.prolong.QT interv., poss.
       723315-001: 1 mg, 30, R221,98  shown to be superior in effic.& may incr.incid.of S/E & should only be   dos.adjustm.with carbamazepine/phenytoin /other concom.hepat.
       723316-001: 2 mg, 30, R476,10  consid.aft.eval.risk vs.benef. Add benzodiazep. if addit.sedat.reqd.  enzyme induc.depend.on indiv. pt. respons., pass.into breastmilk,
       Dosage: Schizophren: When switch.from other antipsychot. & if   Adults: Indiv. Admin.1-2xdly. Init. 2 mg/day. incr.to 4 mg on 2nd   ren./ hepat.impairm., Alzheim.dement., known CV dis. incl. conduct.
       medic.appropriate discont.prev. treatm. grad.& if switch.from depot   day, indiv.furth.if reqd. Usual optim. dos.is 4-8 mg/day. Max.tot.dly.  abnorm./HF/MI/ischaem. cerebrovasc. dis. hist.predispos.to hypo-
       antipsychot. init. Rispide in place of next inj. Re-eval.need for cont. ex-  dos: 16 mg/ day. Elderly: Init.0,5 mg 2x dly.adjust.in 0,5 mg 2xdly.  tens. incl.dehydrat./hypovolaem., seiz.hist./decr.seiz. thresh., per.
       ist.anti-Parkinson meds period. Dos.above 10 mg/day have not been   increm.to 1-2 mg 2x dly.  assessm.in susp.liv.funct.impairm./ new onset liv. disords., discont.
       shown to be superior in effic. & may incr.incid.of S/E & should only be   Behav.disturbs.in pts.with dement: Init. 0,25 mg 2xdly. Indiv.if   if S&S of tard. dyskines.occur, supervis.in high risk suic.pts., 6 mnth.
       consid. aft. eval.risk vs.benef. Add benzodiazep.if addit. sedat.reqd.  necess.in increm.of 0,25 mg 2xdly.not more freq.than every other   eye exam.recomm., grad.withdr., discont.if sympt.of neurolept.malign.
       Adults: Indiv. Admin.1-2xdly. Init. 2 mg/day.incr. to 4 mg on 2nd   day. Optim.dos: 0,5 mg 2xdly.with some benefit. from dos.of upto   syndr.occur & admin. appropr.treatm., cont.lactose.
       day, indiv.furth.if reqd. Usual optim. dos.is 4-8 mg/day. Max.tot.dly.  1 mg 2xdly. Once target.dos. reach.consid. once dly.dos. Eval.cont.  Drug interactions: Centr.effs.of other CNS depress. & alcoh.en-
       dos: 16 mg/ day. Elderly: Init.0,5 mg 2x dly.adjust.in 0,5 mg 2xdly.   treatm.reg.  hanc., poss.antag.act.of dopaminerg. such as levodopa, incr.plasma
       increm.to 1-2 mg 2x dly.      Conduct & disrupt.behav.disords.in childr.5-12 yrs: &lt;50 kg:   conc. with potent inhibits.of CYP3A4, decr.plasma conc. with enzyme
       Behav.disturbs.in pts.with dement: Init: 0,25 mg 2xdly. Indiv.  Init.0,01 mg/kg once dly. Indiv. adjust. in increm.of 0,01 mg/kg once   induc.eg.carbamazepine/phenytoin/ barbits./ rifampicin, incr.clear.
       if necess.in increm.of 0,25 mg 2xdly.not more freq.than every oth-  dly.every other day. Recom.maint.dos: 0,02-0,04 mg/kg once dly.   with concom. thioridazine, oral lorazepam clear.decr.
       er day. Optim. dos: 0,5 mg 2xdly.with some benefit.from dos.of   Mean dos: 0,03 mg/kg once dly. Eval. ongoing need reg.
       upto 1 mg 2xdly. Once target.dos.reach.consid. once dly.dos. Eval.  Contra-indications: Safety & effic.in childr.und. 5 yrs.for con-  SEROQUEL, (Cipla Medpro) AstraZeneca [P/S]
       cont treatm.reg.              duct & other disrupt.behav.disords. not est., Lewy body dement.,   Quetiapine.
       Conduct & disrupt.behav.disords.in childr.5-12 yrs: &lt;50 kg: Init:   pregn.& lactat., safety & effic.in childr.und.15 yrs.for schizophren.   Indications: Schizophren., manic episod.assoc. with bipol.disord.
       0,01 mg/kg once dly. Indiv. adjust. in increm.of 0,01 mg/kg once dly.  not est., galactose intol./lapp lactose defic or gluc.-galact.malab-  (S5) TABS. 32/2.6.5/0589, 0590, 0591, 36/2.6.5/0070
       every other day. Recom.maint.dos: 0,02-0,04 mg/kg once dly. Mean   sopt.as contains lactose  850527-015: 25 mg, 100, R1 215,62
       dos: 0,03 mg/kg once dly. Eval. ongoing need reg.  Side-effects: Tard.dyskines.most.in elderly & esp. elderly fem.,   850535-018: 100 mg, 90, R1 958,99
       Contraindications: Safety & effic.in childr.und.5 yrs. for conduct &   neurolept.malign.syndr., hyperglycaem.assoc.with ketoacidos.&   850543-002: 200 mg, 60, R2 086,31
       other disrupt.behav.disords.not est., Parkinson’s dis.& Lewy body de-  coma/ death, cerebrovasc.accid.& TIA’s, orthostat. hypotens., seiz.,   703344-003: 300 mg, 60, R2 371,85
       ment., safety in pregn.& lactat.not est., safety & effic.in childr. und.15   headache, weight gain, fatig., angio-oed./skin rash & other allerg.  Dosage: Adults: Admin.twice dly. Safety & effic. beyond 12 wks.for
       yrs. for schizophren.not est.  reacts., decr. neutropil &/thrombocyte count, hyperprolactinaem.,   manic episod.assoc.with bi-polar. not demonstrat.
                                                                               st
       Side effects: Freq: Weight gain, rhinit., cough, pharyngit., mod/  water intoxicat.due to polydips./ inappropr.antidiuret.hormone se-  Schizophren: Tot.dly.dos.for 1  4 days: Day 1: 50 mg, day 2: 100 mg,
                                                                                      th
       mental changes incl.agress./ insomn./ agitat./anx./somnol./imp.  cret., galactorrh./gynaecomast./menstr.cycle disturbs. & amenorrh.,   day 3: 200 mg & day 4: 300 mg. Titr.dos.from 4  day to effect.dos.
       concentr., extrapyramid. disord, sedat., dizzin, incr.dreams, trem., ri-  dos.depend.extrapyramid.sympts. incl.trem./rigidity/hypersalivat./  range of 300-450 mg/day. Adj. dos.in some pts.within 150-750 mg/
       gidity, hypersalivat., bradykines., oculogyr. crisis, akathis., ac.dyston.,   bradykines. /oculogyric cris./akathisia/ac.dyston.& hypokines., CNS   day range depend.on clinic.response & tolerab.  st
       hypokines., blurr.vis., decr. salivat., skin rash, itch., urin.incontin., mic-  effs., blurr.vis., tachycard., hypertens., GI disturbs., psych.disords.,   Manic episod.assoc.with bipol.disords: Tot. dly. dos.for 1  4
       turit. disturbs., polyur., erect./ejaculat./orgasm. dysfunct., menstr.cycle   erect.-/ejaculat.-/orgast.dysfunct., priapism, rhinit., urin. incontin.,   days: Day 1: 100 mg, day 2: 200 mg, day 3: 300 mg & day 4: 400 mg.
       disturbs. Less freq: Decr. neutroph./ thrombocyte count., leucopen.,   body temp.disregulat., imp.ment. alertn.  Furth.dos. adjustm. up to 800 mg/day by day 6 should be increm. of
       neutropen., agranulocytos., dyspn., sinusit., URTI, cerebrovasc. dis-  Special precautions: High.mortalit.report.in elderly dement.pts.re-  no great.than 200 mg/day. Adjust.dos. accord. to clinic. respons.within
       ord., TD, NMS, photophob., dry eyes, incr.lacrimat., ocul.hyperaem.,   ceiv.furosemide, avoid dehydrat.in pts.receiv.furosemide, monit.gluc.   200-800 mg/day. Usual effect.dos: 400-800 mg/day.
                                                                  Elderly: Init.25 mg/day, theraft.dly.dos.should be incr. in increm.of
       glauc., eye movem. disord., floppy iris syndr., tachycard., palpitat.,   control in diab.mellit., diab.mellit.risk fact., Parkinson. dis., concom.
       chest pain, atrial fibrillat., anter.ventric. block, QT prolongat., ab-  alcoh.& other central.act. meds., sometimes diffic.to differen.advers.  25-50 mg.to an effect.dos.poss. low. than young.pts.
       norm.ECG, conduct. disords., sinus dysrhythm., orthostat.hypotens.,   effs. from sympts.of underly.psychos., known CV dis. where grad.dos.  (S5) XR TABS, 42/2.6.5/0573, 44/2.6.5/0973, 42/2.6.5/0574,
       hypertens., constip., dyspeps., N&V, abdom.pain, hypersalivat., dry   titrat.recomm., consid.dos. reduct. if hypotens.develops, epilep., ex-  0575, 0576
       skin, incr.pigmentat./sweat., photosens., seborrh., urticar., prurit.,   cret.in human breast milk, ren.& liv.impairm., prescrib.in manner to   Indications: Schizophren., prev.relapse in stable schizophren.pts.
       alopec., eczema, hyperkeratos., back pain, arthralg., gynaecomast.,   minim.TD risk, reg.assess contin.ther., with S&S of tard.dyskines.con-  maint.on Seroquel XR, bipol. disord. incl.manic/depress.episod.as-
       galactorrh., amenorrh. Freq. unknown: Headache, fatig., allerg.  sid.discont., discont. all anti-psychot.& not essent.meds.if neurolept.   soc. with bipol.disord., recurr.prev.in maint.treatm.of bipol. disord. as
                                                                  monother./combin.with a mood stabil., maj. depress.disord., relapse
       reacts., apnoea, pulm.embol., anaphylact.reacts., angioed., water   malign.syndr.develops, consid.re-introduct. caref.& monit. aft.NMS
       intox., body temp.disregulat., incr.plasma prolact. lev., diabet.mellit.  recov.as NMS recurr.report., preventat.hypo-oestrog.bone loss ther.in   prevent.in stabil. maj. depress.disord. pts.maint.on Seroquel XR.
       aggrav., hyperglycaem., mania/ hypomania, intest.obstruct., jaund.,   premenopaus.women with second. amenorrh. of &gt;6mnths., no caus.  713747-002: 50 mg, 60, R792,55
       pancreatit., priapism.        assoc.detect. with report benign pituit.adenomas.  717404-001: 150 mg, 30, R398,35
       Warnings and special precautions: TD risk incr. with ther.du-  Drug interactions: Use with other concom. meds.not system.eval.,   713748-001: 200 mg, 60, R1 650,86
       rat.& tot.cumulat.dos., prescrib. in manner to minim.TD risk, reserve   may antagon.eff.of levodopa & other dopamine agonists, carbamaz-  713749-001: 300 mg, 60, R1 876,82
       treatm.for pts. obtain. substant.benef., reg.assess contin.ther., with   epine & other hepat.enzyme induc.may decr.plasma lev., incr.plasma   713750-001: 400 mg, 60, R2 064,49
       S&S of tard.dyskines.consid.discont., Parkinson. dis/dement.with   lev.with phenothiaz. / TCA’s/some ß-block./fluoxetine.& paroxet., ci-  Dosage: Admin.once dly.. Do not split, chew/ crush.
       Lewy bod.at risk of NMS & incr.antipsychot.med.sensitiv., discont.  metidine & ranitidine incr.bioavailabil.  Adults: Schizophren: Dly.dos: Day 1: 300 mg, Day 2: 600 mg.
                                                                  Aft.day 2 upto 800 mg. Adjust dos.within effect.dos.range of 400-
       all anti-psychot. & not essent.meds.if NMS develops, consid.re-
       introduct.caref.& monit.aft.NMS recov.as NMS recurr.report., high.  SEREZ, AI Pharm Ltd [P/S]  800 mg/day depend.on clinic.respons.& tol. Safety of dos. above
       mortalit. report. in elderly dement.pts.receiv.furosemide, avoid con-  Quetiapine fumarate  800 mg/day not est.
       com. alcoh.& other central.act.meds., avoid dehydrat. in pts.receiv.  Indications: Schizophren., mania assoc with bipol.disord.  Manic episod.assoc.with bipol.disord: Init. dly. dos.: Day 1:
       furosemide, monit. gluc. contr. of exist.diabet./hyperglycaem.sympt.  (S5) TABS. 43/2.6.5/0796, 0797, 0798, 0799  300 mg, day 2: 600 mg & up to 800 mg aft.day 2. Adjust.dos.within ef-
       in those at risk, pts.develop.hyperglycaem.sympt. dur. ther.to undergo   716651-001: 25 mg, 100, R261,53  fect.dos. range of 400-800 mg/day depend.on clinic. respons. & toler.
       fast.bld.gluc.test, cont anti-diab. meds.poss.necess.despite ther.dis-  716652-001: 100 mg, 100, R499,61  Depress.episod.assoc.with bipol.disord: Admin. once dly.in
       cont., high. incid. cerebrovasc.accid.& TIA’s report.in elderly with de-  716653-001: 200 mg, 100, R795,65  even. Titr.as foll: Day 1: 50 mg, day 2:100 mg, day 3: 200 mg, day
       ment., monit.WBC.in hist.of/drug induc. leucopen/ neutropen, monit.  716654-001: 300 mg, 100, R940,45  4: 300 mg. May be titr.to 400 mg on day 5 & up to 600 mg by day 8.
                                                                  No addit.benef.seen in 600 mg group dur.short-term treatm.
       pts.with clinic.signif. neutropen. for fev./other signs of infect., discont.   Dosage: Adults: Admin.twice dly.
                                                  st
       ther. in case of absol.neutroph.count &lt; 1x 10 /l & foll.WBC count until   Schizophren: Tot.dly.dos.for 1  4 days: Day 1: 50 mg, day 2: 100 mg,   Recurr.prev.in maint.treatm.of bipol.disord: Pts. who have
                         9
                                     day 3: 200 mg & day 4: 300 mg. Titr.dos.from 4  day to effect.dos.
                                                                  respond.well to Seroquel XR in combin. ther.with a mood stabil.
                                                         th
       recov., known CV dis./family hist. of QT prolongat./bradycard./electrol.
       disturbs. / concom. meds know to prolong QT interv., known CV dis.  range of 300-450 mg/day. Adj.dos.in indiv.pts.within range of 150-  for ac.treatm.of bipol. disord.should cont. at same dos. May be
       where grad.dos.titrat.recomm., consid.dos. reduct.if hypotens.devel-  750 mg/day depend.on clinic.response & tolerab.  adjust. depend.on indiv.clinic.respons.& toler. within 400-800 mg/
       ops, intraoperat.floppy iris syndr., epilep., refrain from excess.eat., no   Ac.manic episod.assoc.with bipol.disords: Init. dos: Day 1:   day dos.range.
       caus. assoc. detect.with report benign pituit.adenomas., preventat.  50 mg 2x dly, day 2: 100 mg 2x dly, day 3: 150 mg 2x dly.& day 4:   Pts.respond. to Seroquel XR for ac.treatm.of bipol. disord. should cont.
       hypo-oestrog.bone loss ther.in premenopaus. women with second.  200 mg 2x dly. Dos. adjustm.accord.to respons.up to usual range of   at same dos.regim. Dos.may be re-adjust. depend.on indiv. clinic. re-
       amenorrh.of &gt;6 mnths., porphyr., lact.intol., re-eval.ther if concom.   400-800 mg/day. Somet. 200 mg dly may be adeq. Dos. increm.should   spons. & toler. within 300-800 mg/day dos. range.
       fluoxetine/paroxetine init./discont., post-market. advers.effs.observ.  be no great.than 200 mg dly.  Maj.depress.disord: Admin.once dly in even. Init. dos: Day 1 & 2:
       in neonates expos. dur. last trimest.of pregn., excret.in human breast   Elderly: Init.25 mg/day, theraft.dos.may be incr. dly. in increm.of 25-  50 mg incr.to 150 mg on day 3 & 4. Furth. adjustm. can be made upw.
       milk, ren. & hepat.impairm., sometimes diffic.to differen. advers.effs.  50 mg.to an effect.dos.poss. low.than in young.adults.   or downw. within recomm.dos.range of 50-300 mg depend.on clinic.
       from sympts.of underly. psychos., reg.assess contin.ther.  Contraindications: Safety in pregn.& lactat.not est., safety in ad-  respons.& toler. Maint.ther: Cont.with effect. dos.dur.init.treatm. Ad-
       Interactions: Use with other concom.meds.not syst. eval., may   vanc.ren.& liv.impairm.not est., safety & effic.in childr.& adolesc.be-  just dos. within recomm.dos.range depend.on clinic. respons. & toler.
       antagon.eff.of levodopa & other dopamine agon., carbamazepine &   low 18 yrs.not est., concom.CYP3A4 inhibits.such as HIV-protease   Switch.from immed.rel.Seroquel tabs: Switch to XR tabs.at equiv.
       other hepat. enzyme induc.may decr.plasma lev., T max of valproate/ Li   inhibits./erythromycin/clarithromycin/fluconazole/ itraconazole/ke-  tot.dly dos.tak.once dly.
       incr., slight decr.bioavail with topiramate, incr.plasma lev.with pheno-  toconazole, elderly with dement. exhibit.behav.disturbs., rare heredit.  Elderly: Init.50 mg/day. Incr.in increm.of 50 mg/ day to effect.dos.
       thiaz./ TCA’s/ some ß-block./fluoxetine/paroxetine & CYP2D6 inhibit.,   galact.probl., Lapp lact.defic., gluc.-galact.tol.malabsorpt.  depend.on clinic.respons.& toler.
       incr AUC & decr.clear.with concom. venlafaxine, cimetidine & raniti-  Side effects: Hyperglycaem.sometim.extreme assoc. with ketoac-  Contraindications: Safety in pregn.& lactat.not est., safety in ad-
       dine incr. bioavail., clin.signif.hypotens.with concom. antihypertens.  idos./hyperosmol.coma/death, incr. cerebrovasc.events esp.elderly,   vanc.liv.impairm.not est., safety & effic.in childr.& adolesc. not est.
                                     hypersens. reacts. incl.Stev.-Johns.syndr./angioed., bld. disords.,
                                                                  Side effects: Hyperglycaem.sometim.extreme assoc. with ketoaci-
       RISPONZ, Zydus [P/S]          fev., chills, sore throat, hypothyroid., pre-exist.diabet.exacerbat., ab-  dos./coma/death, somnol., dizzin., dry mouth, asthen., GI disturbs.,
       Risperidone                   norm.dreams, nightmar., dizzin., drowsin., somnol., extrapyramid./   tachycard., weight gain., syncope, neurolept. malign.syndr., bld.dys-
       Indications: Ac.& chron.schizophren.psychos.& relat. psychos.  parkinson. sympt., neurolept.malign.syndr., seiz., anx., potent.tard.  cras., periph.oed., rhinit., hypersens. reacts.incl.anaphylax., seiz.,
       where posit.&/or negat.sympts.are promin., behav.disturbs.in pts.  dyskines., eye/vis.disords., ear pain, orthostat.hypotens., hypertens.,   restless legs syndr., fev., priapism, orthostat.hypotens. esp. dur.init.
       with dement.when aggressiven./activ.disturbs./psychot. sympts.  ven. thromboembol., palpitat., prolongat.of QTc interv., dyspn., phar-  titr.period, dos.relat.decr.in thyroid horm. lev., cholesterol & triglyc-</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page59.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page55.html">55</a>&nbsp;&nbsp;&nbsp;<a href="page56.html">56</a>&nbsp;&nbsp;&nbsp;<a href="page57.html">57</a>&nbsp;&nbsp;&nbsp;<a href="page58.html">58</a>&nbsp;&nbsp;&nbsp;<a href="page59.html">59</a>&nbsp;&nbsp;&nbsp;<a href="page60.html">60</a>&nbsp;&nbsp;&nbsp;<a href="page61.html">61</a>&nbsp;&nbsp;&nbsp;<a href="page62.html">62</a>&nbsp;&nbsp;&nbsp;<a href="page63.html">63</a>&nbsp;&nbsp;&nbsp;<a href="page64.html">64</a>&nbsp;&nbsp;&nbsp;<a href="page65.html">65</a>
             </td>
             <td width="35%"><a href="page61.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page61.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
